The presence of cutaneous changes in systemic diseases has been particularly emphasized ... disseminated variety in which the patient has a mild elevation of temperature, malaise, leukopenia ...

Symptom control Use of rapidly acting agents tailored to the nature and severity of the manifestation Glucocorticoids: topical for mild cutaneous lupus; low-dose oral for mild disease; moderate to ...

Scientists in London have found that even mild cases of the virus could trigger long-lasting effects on the brain, possibly increasing the risk of the brain-eating disease Alzheimer's ...

A new study has found that Covid-19 could affect brain proteins linked to Alzheimer's disease, the most common form of ...

MANY people who have had Covid-19 will be familiar with the ‘brain fog’ that lingers in the weeks or months after getting ...

COVID-19, even in mild cases, is linked to changes in Alzheimer’s disease-related brain biomarkers comparable to four years ...

ASA 1: Clinically healthy. ASA 2: Mild systemic disease without significant functional limitation. Some ASA 3: Severe systemic disease with significant functional limitation – clinical discretion ...

Prolonged rapid eye movement (REM) sleep latency was linked with Alzheimer's disease biomarkers, cross-sectional data showed.

Current treatment options for systemic lupus erythematosus (SLE ... low-dose oral for mild disease; moderate to high-dose oral for more severe disease; intravenous for very severe or life ...